Harmony Biosciences to Participate in Goldman Sachs 46th Annual Global Healthcare Conference

Audio By Carbonatix

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Jun 4, 2025--

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in a fireside chat at the Goldman Sachs 46 th Annual Global Healthcare Conference in Miami, FL on Monday, June 9, 2025, at 3:20 p.m., ET

A webcast of the fireside chat will be available on the investor page of the Harmony Biosciences website at https://ir.harmonybiosciences.com/.

About Harmony Biosciences

Harmony Biosciences is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. Driven by novel science, visionary thinking, and a commitment to those who feel overlooked, Harmony Biosciences is nurturing a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, Pa, we believe that when empathy and innovation meet, a better future can begin; a vision evident in the therapeutic innovations we advance, the culture we cultivate, and the community programs we foster. For more information, please visit www.harmonybiosciences.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250604464007/en/

CONTACT: Harmony Biosciences Investor Contact:

Brennan Doyle

484-539-9700

[email protected] Biosciences Media Contact:

Cate McCanless

202-641-6086

[email protected]

KEYWORD: PENNSYLVANIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: RESEARCH NEUROLOGY BIOTECHNOLOGY OTHER HEALTH HEALTH PHARMACEUTICAL GENERAL HEALTH OTHER SCIENCE SCIENCE

SOURCE: Harmony Biosciences Holdings, Inc.

Copyright Business Wire 2025.

PUB: 06/04/2025 08:05 AM/DISC: 06/04/2025 08:04 AM

http://www.businesswire.com/news/home/20250604464007/en